Trials / Completed
CompletedNCT01496183
Metabolic Effects of Olanzapine in Healthy Males
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- State University of New York at Buffalo · Academic / Other
- Sex
- Male
- Age
- 18 Years – 35 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to look at how a two-week use of a medication called Olanzapine might change appetite, physical activity, resting metabolic rate, body composition, and weight in healthy men.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Olanzapine | Olanzapine 5mg capsule administered orally at bedtime for 7 days followed by Olanzapine 10 mg capsule administered orally at bedtime for 7 days. |
| DRUG | Placebo | Placebo capsule administered orally at bedtime for 14 days |
Timeline
- Start date
- 2007-10-01
- Primary completion
- 2013-04-01
- Completion
- 2013-04-01
- First posted
- 2011-12-21
- Last updated
- 2018-08-16
- Results posted
- 2014-12-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01496183. Inclusion in this directory is not an endorsement.